WebAug 9, 2024 · INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from infectious diseases, cancer, and diseases associated with HPV. Our DNA medicines are delivered using our proprietary smart device to produce immune responses against targeted pathogens and … WebNov 9, 2024 · INOVIO is also evaluating INO-4800, a vaccine candidate against COVID-19, in a Phase 2/3 clinical trial; the Phase 3 segment of which has received regulatory authorizations to proceed in Colombia ...
571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA …
WebJul 11, 2024 · INOVIO Pharmaceuticals has 262 employees. 41% of INOVIO Pharmaceuticals employees are women, while 59% are men. The most common ethnicity at INOVIO Pharmaceuticals is White (47%). 27% of INOVIO Pharmaceuticals employees are Asian. 15% of INOVIO Pharmaceuticals employees are Hispanic or Latino. WebTotal Compensation. $6,223,600 View details. Pay Rank By Title In MFG Durable industry. #320 View more. The charts on this page feature a breakdown of the total annual pay for … generalization text pattern
EMPLOYMENT AGREEMENT INOVIO PHARMACEUTICALS, INC.
WebApr 12, 2024 · Inovio Pharmaceuticals, Inc. 0.7290 +0.0007 ... A new survey highlights the gap between employee burnout and company awareness. How often have you been “exhausted by excessive demands on energy ... WebThe company is focused on developing and commercializing DNA medicines to potentially treat and protect people from infectious diseases, cancer, and diseases associated with … WebNov 8, 2024 · INOVIO reported total revenue of $9.2 million for the three months ended, September 30, 2024, compared to $292,000 for the same period in 2024. The increase in revenue resulted from the fulfillment of obligations under its contract with the U.S. Department of Defense. generalization toolset